Trial intelligence / Profile preview

Resistance to IGF-1 generation in non-GH deficient short children with low IGF-1

2009-012089-30Phase 4Completed

Sponsor
UZ Brussel
Start
May 2009
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of somatropin in growth disorder and insulin-like growth factor 1 deficiency, sponsored by UZ Brussel. Primary endpoint: Discordant IGF generation test frequency. Started May 2009; status: completed.

02

Drugs

somatropin
03

Conditions

growth disorderinsulin-like growth factor 1 deficiency

Beyond the preview

Go deeper on 2009-012089-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-012089-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call